DONALD C. MANNING, M.D., PH.D
Osteopathic Medicine at Ray C Hunt Dr, Charlottesville, VA
License number
Virginia 0101049588
Category
Osteopathic Medicine
Type
Pain Medicine
Address
Address
2
545 Ray C Hunt Dr, Charlottesville, VA 22903
16 Johnston Dr, Bloomsbury, NJ 08804
16 Johnston Dr, Bloomsbury, NJ 08804
Phone
(434) 924-2283
(434) 982-0019 (Fax)
(908) 892-5229
(973) 966-2820 (Fax)
(434) 982-0019 (Fax)
(908) 892-5229
(973) 966-2820 (Fax)
Personal information
See more information about DONALD C. MANNING at radaris.comName
Address
Phone
571 Autumn Dr, Evington, VA 24550
60 Oak Dr, Stafford, VA 22554
40 Waterman Ave, Rumson, NJ 07760
4624 Stonebridge Ln, Virginia Beach, VA 23462
446 Richmond Ave, Maplewood, NJ 07040
Professional information
Dr. Donald C Manning, Charlottesville VA - MD (Doctor of Medicine)
Specialties:
Anesthesiology, Pain Medicine Anesthesiology
Address:
545 Ray C Hunt Dr SUITE 316, Charlottesville 22903
(434) 924-2283 (Phone), (434) 982-0019 (Fax)
(434) 924-2283 (Phone), (434) 982-0019 (Fax)
Certifications:
Anesthesiology, 1993, Pain Medicine, 2007
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
545 Ray C Hunt Dr SUITE 316, Charlottesville 22903
Education:
Medical School
Johns Hopkins University / School of Medicine
Union Memorial Hospital
Johns Hopkins University School Of Med
Johns Hopkins University / School of Medicine
Union Memorial Hospital
Johns Hopkins University School Of Med
Use Of Oxcarbazepine For The Treatment Of Diabetic Neuropathic Pain And The Improvement Of Sleep
US Patent:
2006027, Nov 30, 2006
Filed:
Sep 2, 2004
Appl. No.:
10/570340
Inventors:
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K 31/55
US Classification:
514217000
Abstract:
The present invention provides for novel uses of the carbamazepine derivative of formula (I)
and its pharmaceutically acceptable salts, in particular an improved regiment for the administration of the carbamazepine derivative of formula (I) and the pharmaceutically acceptable salts thereof for the treatment of patients suffering from pin, in particular neuropathic paid, and the improvement of sleep; the use of oxcarbazepine for the manufacture of a pharmaceutical composition for the treatment of pain or the manufacture of a pharmaceutical composition for the improvement of sleep in human patients suffering from chronic pain; pharmaceutical composition comprising oxcarbazepine as sole active ingredient for the treatment of pain or for the improvement of sleep in human patients suffering from chronic pain and to packages comprising a pharmaceutical composition comprising as sole active ingredient oxcarbazepine together with instructions for the treatment of pain or together with instructions for improvement of sleep in human patients suffering from chronic pain.
Methods For Treatment, Modification And Management Of Radiculopathy Using 1-Oxo-2-(2,6-Dioxopiperidin-3Yl)-4-Aminoisoindoline
US Patent:
7612096, Nov 3, 2009
Filed:
Apr 23, 2004
Appl. No.:
10/576152
Inventors:
Jerome B. Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald C. Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald C. Manning - Bloomsbury NJ, US
Assignee:
Celgene Corporation - Summit NJ
International Classification:
A01N 43/40, A61K 31/445
US Classification:
514323, 514315, 514317, 514319, 514320
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Using And Compositions Comprising Selective Cytokine Inhibitory Drugs For Treatment, Modification And Management Of Pain
US Patent:
2004008, May 6, 2004
Filed:
Oct 23, 2003
Appl. No.:
10/693722
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K031/60, A61K031/573, A61K031/485, A61K031/445, A61K031/192, A61K031/19
US Classification:
514/165000, 514/282000, 514/217000, 514/317000, 514/569000, 514/570000, 514/171000, 514/557000, 514/561000, 514/035000, 514/629000
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Using And Compositions Comprising Selective Cytokine Inhibitory Drugs For Treatment, Modification And Management Of Pain
US Patent:
2007016, Jul 12, 2007
Filed:
Apr 23, 2004
Appl. No.:
10/576139
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K 31/4035, A61K 31/7048, A61K 31/60, A61K 31/573, A61K 31/55, A61K 31/445, A61K 31/485, A61K 31/192, A61K 31/4166, A61K 31/405, A61K 31/198
US Classification:
514417000, 514165000, 514171000, 514217000, 514282000, 514420000, 514317000, 514557000, 514569000, 514570000, 514028000, 514561000, 514389000
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of a selective cytokine inhibitory drug, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Using And Compositions Comprising A Jnk Inhibitor For The Treatment, Prevention, Management And/Or Modification Of Pain
US Patent:
2004008, May 6, 2004
Filed:
Oct 23, 2003
Appl. No.:
10/693793
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K031/416
US Classification:
514/406000
Abstract:
The present invention relates to methods for treating, preventing, managing and/or modifying pain, comprising administering an effective amount of a JNK Inhibitor to a patient in need thereof. Specific embodiments encompass the administration of a JNK Inhibitor, alone or in combination with a second active agent and/or surgery or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods And Compositions For The Treatment, Prevention Or Management Of Dysfunctional Sleep And Dysfunctional Sleep Associated With Disease
US Patent:
2005022, Oct 6, 2005
Filed:
Mar 30, 2005
Appl. No.:
11/093848
Inventors:
Jerome Zeldis - Princeton NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
International Classification:
A61K031/454
US Classification:
514323000
Abstract:
Methods of treating, preventing and/or managing dysfunctional sleep, including but not limited to, dysfunctional sleep associated with chronic neurological or inflammatory condition such as pain and neurodegenerative disorders, which comprise the administration of one or more immunomodulatory compounds or a pharmaceutically acceptable salt, solvate, stereoisomer, clathrate or prodrug thereof, alone or in combination with known therapeutics are disclosed. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods And Compositions Using Jnk Inhibitors For Treatment And Management Of Central Nervous System Injury
US Patent:
2006012, Jun 8, 2006
Filed:
Nov 22, 2005
Appl. No.:
11/286128
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K 31/5377, A61K 31/4245, A61K 31/454, A61K 31/4196, A61K 31/416
US Classification:
514232500, 514322000, 514383000, 514381000, 514364000, 514406000
Abstract:
Methods of treating, preventing and/or managing a central nervous system injury/damage and related syndromes are disclosed. Specific methods encompass the administration of a JNK inhibitor alone or in combination with a second active agent. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods And Compositions Using Immunomodulatory Compounds For Treatment And Management Of Central Nervous System Injury
US Patent:
2006012, Jun 8, 2006
Filed:
Nov 18, 2005
Appl. No.:
11/284403
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K 31/454
US Classification:
514323000
Abstract:
Methods of treating, preventing and/or managing a central nervous system injury/damage and related syndromes are disclosed. Specific methods encompass the administration of an immunomodulatory compound alone or in combination with a second active agent. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.
Methods Of Using And Compositions Comprising Immunomodulatory Compounds For Treatment, Modification And Management Of Pain
US Patent:
2005020, Sep 15, 2005
Filed:
Oct 23, 2003
Appl. No.:
10/693794
Inventors:
Jerome Zeldis - Princeton NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
Herbert Faleck - West Orange NJ, US
Donald Manning - Bloomsbury NJ, US
International Classification:
A61K031/454
US Classification:
514323000
Abstract:
Methods of treating, preventing, modifying and managing various types of pain are disclosed. Specific methods comprise the administration of an immunomodulatory compound, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active agent and/or surgery, psychological or physical therapy. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in methods of the invention are also disclosed.